查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1530936

前列腺健康市場 - 全球產業分析、規模、佔有率、成長、趨勢和預測，2024-2034 年

Prostate Health Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
出版日期: | 出版商: Transparency Market Research | 英文 213 Pages | 商品交期: 2-10個工作天內

價格

攝護腺健康市場 - 報告範圍

TMR 關於全球前列腺健康市場的報告研究了過去以及當前的成長趨勢和機會，以獲得 2024 年至 2034 年預測期內市場指標的寶貴見解。 ，考慮2024年為基準年，2034年為預測年。報告中也提供了2024年至2034年全球攝護腺健康市場的年複合成長率（CAGR%）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解前列腺健康市場。

市場概況
2023年市場價值 3190萬美元
2034 年市場價值 838 億美元
複合年成長率 9.2%

該報告深入研究了全球前列腺健康市場的競爭格局。全球前列腺健康市場的主要參與者已被確定，並且每一位參與者都已根據各種屬性進行了分析。公司概況、財務狀況、最新發展和 SWOT 是本報告中介紹的全球前列腺健康市場參與者的屬性。

目錄

第1章：前言

第 2 章：假設與研究方法

第 3 章：執行摘要：全球市場

第 4 章：市場概覽

  • 介紹
  • 概述
  • 市場動態
  • 2020-2034年全球市場分析與預測

第 5 章：關鍵見解

  • 按地區/全球分類的監管情景
  • 關鍵產業活動（產品發布、合作與夥伴關係、收購、核准等）
  • 管道分析
  • 主要國家的報銷情況
  • 攝護腺疾病（攝護腺炎、良性攝護腺增生、攝護腺癌等）的疾病診斷
  • 品牌分析
  • 定價分析
  • Covid-19 大流行對該行業的影響

第 6 章：全球市場分析與預測：依疾病類型

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：依疾病類型，2020-2034
    • 攝護腺炎
    • 良性攝護腺增生（BPH）
    • 攝護腺癌
      • 腺癌
      • 移行細胞癌
      • 鱗狀細胞癌
      • 小細胞前列腺癌
  • 市場吸引力分析：按疾病類型

第 7 章：全球市場分析與預測：按處理方式

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：依處理方式，2020-2034
    • 化療
    • 荷爾蒙療法
    • 免疫療法
  • 市場吸引力分析：按處理方式

第 8 章：全球市場分析與預測：按管理途徑

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：依給藥途徑，2020-2034年
    • 口服
    • 注射用
  • 市場吸引力分析：按給藥途徑

第 9 章：全球市場分析與預測：按配銷通路

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：按配銷通路，2020-2034
    • 醫院藥房
    • 零售藥局
    • 網路藥局
  • 市場吸引力分析：按配銷通路

第 10 章：全球市場分析與預測：按地區

  • 主要發現
  • 市場價值預測：按地區，2020-2034
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 按地區分類的市場吸引力

第 11 章：北美市場分析與預測

第 12 章：歐洲市場分析與預測

第 13 章：亞太市場分析與預測

第 14 章：拉丁美洲市場分析與預測

第 15 章：中東和非洲市場分析與預測

第16章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 公司市佔率分析 (2023)
  • 公司簡介
    • Abbott Laboratories
    • Amgen Inc.
    • Astellas Pharma Inc.
    • AstraZeneca PLC
    • Bayer AG
    • Bristol-Myers Squibb (BMS)
    • Eli Lilly and Company
    • Ferring Pharmaceuticals
    • GSK PLC.
    • Johnson & Johnson
    • Merck and Co. Inc.
    • Pfizer Inc.
    • Siemens Healthineers AG
Product Code: TMRGL84727

Prostate Health Market - Scope of Report

TMR's report on the global prostate health market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global prostate health market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global prostate health market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the prostate health market.

Market Snapshot
Market Value in 2023US$ 31.9 Mn
Market Value in 2034US$ 83.8 Bn
CAGR9.2%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global prostate health market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global prostate health market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global prostate health market.

The report delves into the competitive landscape of the global prostate health market. Key players operating in the global prostate health market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global prostate health market profiled in this report.

Key Questions Answered in Global prostate health Market Report:

  • What is the sales/revenue generated by prostate health across all regions during the forecast period?
  • What are the opportunities in the global prostate health market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Prostate Health Market - Research Objectives and Research Approach

The comprehensive report on the global prostate health market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global prostate health market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global prostate health market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Prostate Health Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Prostate Health Market Analysis and Forecast, 2020-2034
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Regulatory Scenario by region/globally
  • 5.2. Key Industry Events (Product Launches, Collaborations and Partnerships, Acquisitions, Approvals etc.)
  • 5.3. Pipeline Analysis
  • 5.4. Reimbursement Scenario by Key Countries
  • 5.5. Disease Diagnosis of Prostate Diseases (Prostatitis, Benign Prostate Hyperplasia, Prostate Cancer, etc.)
  • 5.6. Brand Analysis
  • 5.7. Pricing Analysis
  • 5.8. Covid-19 Pandemic Impact on Industry

6. Global Prostate Health Market Analysis and Forecast, by Disease Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Disease Type, 2020-2034
    • 6.3.1. Prostatitis
    • 6.3.2. Benign Prostatic Hyperplasia (BPH)
    • 6.3.3. Prostate Cancer
      • 6.3.3.1. Adenocarcinoma
      • 6.3.3.2. Transitional Cell Carcinoma
      • 6.3.3.3. Squamous Cell Carcinoma
      • 6.3.3.4. Small Cell Prostate Cancer
  • 6.4. Market Attractiveness Analysis, by Disease Type

7. Global Prostate Health Market Analysis and Forecast, by Treatment

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Treatment, 2020-2034
    • 7.3.1. Chemotherapy
    • 7.3.2. Hormone Therapy
    • 7.3.3. Immunotherapy
  • 7.4. Market Attractiveness Analysis, by Treatment

8. Global Prostate Health Market Analysis and Forecast, by Route of Administration

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Route of Administration, 2020-2034
    • 8.3.1. Oral
    • 8.3.2. Parenteral
  • 8.4. Market Attractiveness Analysis, by Route of Administration

9. Global Prostate Health Market Analysis and Forecast, by Distribution Channel

  • 9.1. Introduction & Definition
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by Distribution Channel, 2020-2034
    • 9.3.1. Hospital Pharmacies
    • 9.3.2. Retail Pharmacies
    • 9.3.3. Online Pharmacies
  • 9.4. Market Attractiveness Analysis, by Distribution Channel

10. Global Prostate Health Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2020-2034
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Region

11. North America Prostate Health Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Disease Type, 2020-2034
    • 11.2.1. Prostatitis
    • 11.2.2. Benign Prostatic Hyperplasia (BPH)
    • 11.2.3. Prostate Cancer
      • 11.2.3.1. Adenocarcinoma
      • 11.2.3.2. Transitional Cell Carcinoma
      • 11.2.3.3. Squamous Cell Carcinoma
      • 11.2.3.4. Small Cell Prostate Cancer
  • 11.3. Market Value Forecast, by Treatment, 2020-2034
    • 11.3.1. Chemotherapy
    • 11.3.2. Hormone Therapy
    • 11.3.3. Immunotherapy
  • 11.4. Market Value Forecast, by Route of Administration, 2020-2034
    • 11.4.1. Oral
    • 11.4.2. Parenteral
  • 11.5. Market Value Forecast, by Distribution Channel, 2020-2034
    • 11.5.1. Hospital Pharmacies
    • 11.5.2. Retail Pharmacies
    • 11.5.3. Online Pharmacies
  • 11.6. Market Value Forecast, by Country
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Disease Type
    • 11.7.2. By Treatment
    • 11.7.3. By Route of Administration
    • 11.7.4. By Distribution Channel
    • 11.7.5. By Country

12. Europe Prostate Health Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Disease Type, 2020-2034
    • 12.2.1. Prostatitis
    • 12.2.2. Benign Prostatic Hyperplasia (BPH)
    • 12.2.3. Prostate Cancer
      • 12.2.3.1. Adenocarcinoma
      • 12.2.3.2. Transitional Cell Carcinoma
      • 12.2.3.3. Squamous Cell Carcinoma
      • 12.2.3.4. Small Cell Prostate Cancer
  • 12.3. Market Value Forecast, by Treatment, 2020-2034
    • 12.3.1. Chemotherapy
    • 12.3.2. Hormone Therapy
    • 12.3.3. Immunotherapy
  • 12.4. Market Value Forecast, by Route of Administration, 2020-2034
    • 12.4.1. Oral
    • 12.4.2. Parenteral
  • 12.5. Market Value Forecast, by Distribution Channel, 2020-2034
    • 12.5.1. Hospital Pharmacies
    • 12.5.2. Retail Pharmacies
    • 12.5.3. Online Pharmacies
  • 12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 12.6.1. Germany
    • 12.6.2. UK
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Disease Type
    • 12.7.2. By Treatment
    • 12.7.3. By Route of Administration
    • 12.7.4. By Distribution Channel
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Prostate Health Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Disease Type, 2020-2034
    • 13.2.1. Prostatitis
    • 13.2.2. Benign prostatic hyperplasia (BPH)
    • 13.2.3. Prostate Cancer
      • 13.2.3.1. Adenocarcinoma
      • 13.2.3.2. Transitional Cell Carcinoma
      • 13.2.3.3. Squamous Cell Carcinoma
      • 13.2.3.4. Small Cell Prostate Cancer
  • 13.3. Market Value Forecast, by Treatment, 2020-2034
    • 13.3.1. Chemotherapy
    • 13.3.2. Hormone Therapy
    • 13.3.3. Immunotherapy
  • 13.4. Market Value Forecast, by Route of Administration, 2020-2034
    • 13.4.1. Oral
    • 13.4.2. Parenteral
  • 13.5. Market Value Forecast, by Distribution Channel, 2020-2034
    • 13.5.1. Hospital Pharmacies
    • 13.5.2. Retail Pharmacies
    • 13.5.3. Online Pharmacies
  • 13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Disease Type
    • 13.7.2. By Treatment
    • 13.7.3. By Route of Administration
    • 13.7.4. By Distribution Channel
    • 13.7.5. By Country/Sub-region

14. Latin America Prostate Health Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Disease Type, 2020-2034
    • 14.2.1. Prostatitis
    • 14.2.2. Benign prostatic hyperplasia (BPH)
    • 14.2.3. Prostate Cancer
      • 14.2.3.1. Adenocarcinoma
      • 14.2.3.2. Transitional Cell Carcinoma
      • 14.2.3.3. Squamous Cell Carcinoma
      • 14.2.3.4. Small Cell Prostate Cancer
  • 14.3. Market Value Forecast, by Treatment, 2020-2034
    • 14.3.1. Chemotherapy
    • 14.3.2. Hormone Therapy
    • 14.3.3. Immunotherapy
  • 14.4. Market Value Forecast, by Route of Administration, 2020-2034
    • 14.4.1. Oral
    • 14.4.2. Parenteral
  • 14.5. Market Value Forecast, by Distribution Channel, 2020-2034
    • 14.5.1. Hospital Pharmacies
    • 14.5.2. Retail Pharmacies
    • 14.5.3. Online Pharmacies
  • 14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Disease Type
    • 14.7.2. By Treatment
    • 14.7.3. By Route of Administration
    • 14.7.4. By Distribution Channel
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Prostate Health Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Disease Type, 2020-2034
    • 15.2.1. Prostatitis
    • 15.2.2. Benign prostatic hyperplasia (BPH)
    • 15.2.3. Prostate Cancer
      • 15.2.3.1. Adenocarcinoma
      • 15.2.3.2. Transitional Cell Carcinoma
      • 15.2.3.3. Squamous Cell Carcinoma
      • 15.2.3.4. Small Cell Prostate Cancer
  • 15.3. Market Value Forecast, by Treatment, 2020-2034
    • 15.3.1. Chemotherapy
    • 15.3.2. Hormone Therapy
    • 15.3.3. Immunotherapy
  • 15.4. Market Value Forecast, by Route of Administration, 2020-2034
    • 15.4.1. Oral
    • 15.4.2. Parenteral
  • 15.5. Market Value Forecast, by Distribution Channel, 2020-2034
    • 15.5.1. Hospital Pharmacies
    • 15.5.2. Retail Pharmacies
    • 15.5.3. Online Pharmacies
  • 15.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Disease Type
    • 15.7.2. By Treatment
    • 15.7.3. By Route of Administration
    • 15.7.4. By Distribution Channel
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 16.2. Market Share Analysis By Company (2023)
  • 16.3. Company Profiles
    • 16.3.1. Abbott Laboratories
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Amgen Inc.
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Astellas Pharma Inc.
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. AstraZeneca PLC
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Bayer AG
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Bristol-Myers Squibb (BMS)
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Eli Lilly and Company
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Ferring Pharmaceuticals
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. GSK PLC.
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Johnson & Johnson
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview
    • 16.3.11. Merck and Co. Inc.
      • 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.11.2. Product Portfolio
      • 16.3.11.3. Financial Overview
      • 16.3.11.4. SWOT Analysis
      • 16.3.11.5. Strategic Overview
    • 16.3.12. Pfizer Inc.
      • 16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.12.2. Product Portfolio
      • 16.3.12.3. Financial Overview
      • 16.3.12.4. SWOT Analysis
      • 16.3.12.5. Strategic Overview
    • 16.3.13. Siemens Healthineers AG
      • 16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.13.2. Product Portfolio
      • 16.3.13.3. Financial Overview
      • 16.3.13.4. SWOT Analysis
      • 16.3.13.5. Strategic Overview

List of Tables

  • Table 01: Global Prostate Health Market Value (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 02: Global Prostate Health Market Value (US$ Mn) Forecast, by Prostate cancer, 2020-2034
  • Table 03: Global Prostate Health Market Value (US$ Mn) Forecast, by Treatment, 2020-2034
  • Table 04: Global Prostate Health Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 05: Global Prostate Health Market Value (US$ Mn) Forecast, by Region, 2020-2034
  • Table 06: North America Prostate Health Market Value (US$ Mn) Forecast, by Country, 2020-2034
  • Table 07: North America Prostate Health Market Value (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 08: North America Prostate Health Market Value (US$ Mn) Forecast, by Prostate Cancer, 2020-2034
  • Table 09: North America Prostate Health Market Value (US$ Mn) Forecast, by Treatment, 2020-2034
  • Table 10: North America Prostate Health Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 11: Europe Prostate Health Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 12: Europe Prostate Health Market Value (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 13: Europe Prostate Health Market Value (US$ Mn) Forecast, by Prostate Cancer, 2020-2034
  • Table 14: Europe Prostate Health Market Value (US$ Mn) Forecast, by Treatment, 2020-2034
  • Table 15: Europe Prostate Health Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 16: Asia Pacific Prostate Health Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 17: Asia Pacific Prostate Health Market Value (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 18: Asia Pacific Prostate Health Market Value (US$ Mn) Forecast, by Prostate Cancer, 2020-2034
  • Table 19: Asia Pacific Prostate Health Market Value (US$ Mn) Forecast, by Treatment, 2020-2034
  • Table 20: Asia Pacific Prostate Health Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 21: Latin America Prostate Health Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Latin America Prostate Health Market Value (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 23: Latin America Prostate Health Market Value (US$ Mn) Forecast, by Prostate Cancer, 2020-2034
  • Table 24: Latin America Prostate Health Market Value (US$ Mn) Forecast, by Treatment, 2020-2034
  • Table 25: Latin America Prostate Health Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 26: Middle East & Africa Prostate Health Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 27: Middle East & Africa Prostate Health Market Value (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 28: Middle East & Africa Prostate Health Market Value (US$ Mn) Forecast, by Prostate Cancer, 2020-2034
  • Table 29: Middle East & Africa Prostate Health Market Value (US$ Mn) Forecast, by Treatment, 2020-2034
  • Table 30: Middle East & Africa Prostate Health Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034

List of Figures

  • Figure 01: Global Prostate Health Market Value (US$ Mn) Forecast, 2020-2034
  • Figure 02: Global Prostate Health Market Value Share, by Disease Type, 2023
  • Figure 03: Global Prostate Health Market Value Share, by Treatment, 2023
  • Figure 04: Global Prostate Health Market Value Share, by Route of Administration, 2023
  • Figure 05: Global Prostate Health Market Value Share, by Distribution Channel, 2023
  • Figure 06: Global Prostate Health Market Value Share, by Region, 2023
  • Figure 07: Global Prostate Health Market Value (US$ Mn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 08: Global Prostate Health Market Share Analysis, by Disease Type, 2023
  • Figure 09: Global Prostate Health Market Share Analysis, by Disease Type, 2034
  • Figure 10: Global Prostate Health Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 11: Global Prostate Health Market Value (US$ Mn), by Prostatitis, 2020-2034
  • Figure 12: Global Prostate Health Market Value Share Analysis, by Prostatitis, 2023 and 2034
  • Figure 13: Global Prostate Health Market Value (US$ Mn), by Benign prostatic hyperplasia (BPH), 2020-2034
  • Figure 14: Global Prostate Health Market Value Share Analysis, by Benign prostatic hyperplasia (BPH), 2023 and 2034
  • Figure 15: Global Prostate Health Market Value (US$ Mn), by Prostate cancer, 2020-2034
  • Figure 16: Global Prostate Health Market Value Share Analysis, by Prostate cancer, 2023 and 2034
  • Figure 17: Global Prostate Health Market Value (US$ Mn) Share Analysis, by Treatment, 2023 and 2034
  • Figure 18: Global Prostate Health Market Share Analysis, by Treatment, 2023
  • Figure 19: Global Prostate Health Market Share Analysis, by Treatment, 2034
  • Figure 20: Global Prostate Health Market Attractiveness Analysis, by Treatment, 2024-2034
  • Figure 21: Global Prostate Health Market Value (US$ Mn), by Chemotherapy, 2020-2034
  • Figure 22: Global Prostate Health Market Value Share Analysis, by Chemotherapy, 2023 and 2034
  • Figure 23: Global Prostate Health Market Value (US$ Mn), by Hormone Therapy, 2020-2034
  • Figure 24: Global Prostate Health Market Value Share Analysis, by Hormone Therapy, 2023 and 2034
  • Figure 25: Global Prostate Health Market Value (US$ Mn), by Immunotherapy, 2020-2034
  • Figure 26: Global Prostate Health Market Value Share Analysis, by Immunotherapy, 2023 and 2034
  • Figure 27: Global Prostate Health Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 28: Global Prostate Health Market Share Analysis, by Distribution Channel, 2023
  • Figure 29: Global Prostate Health Market Share Analysis, by Distribution Channel, 2034
  • Figure 30: Global Prostate Health Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 31: Global Prostate Health Market Value (US$ Mn), by Hospital Pharmacies, 2020-2034
  • Figure 32: Global Prostate Health Market Value Share Analysis, by Hospital Pharmacies, 2023 and 2034
  • Figure 33: Global Prostate Health Market Value (US$ Mn), by Retail Pharmacies, 2020-2034
  • Figure 34: Global Prostate Health Market Value Share Analysis, by Retail Pharmacies, 2023 and 2034
  • Figure 35: Global Prostate Health Market Value (US$ Mn), by Online Pharmacies, 2020-2034
  • Figure 36: Global Prostate Health Market Value Share Analysis, by Online Pharmacies, 2023 and 2034
  • Figure 37: Global Prostate Health Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 38: Global Prostate Health Market Share Analysis, by Region, 2023
  • Figure 39: Global Prostate Health Market Share Analysis, by Region, 2034
  • Figure 40: Global Prostate Health Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 41: North America Prostate Health Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 42: North America Prostate Health Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 43: North America Prostate Health Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 44: North America Prostate Health Market Value (US$ Mn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 45: North America Prostate Health Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 46: North America Prostate Health Market Value (US$ Mn) Share Analysis, by Treatment, 2023 and 2034
  • Figure 47: North America Prostate Health Market Attractiveness Analysis, by Treatment, 2024-2034
  • Figure 48: North America Prostate Health Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 49: North America Prostate Health Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 50: Europe Prostate Health Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 51: Europe Prostate Health Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 52: Europe Prostate Health Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 53: Europe Prostate Health Market Value (US$ Mn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 54: Europe Prostate Health Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 55: Europe Prostate Health Market Value (US$ Mn) Share Analysis, by Treatment, 2023 and 2034
  • Figure 56: Europe Prostate Health Market Attractiveness Analysis, by Treatment, 2024-2034
  • Figure 57: Europe Prostate Health Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 58: Europe Prostate Health Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 59: Asia Pacific Prostate Health Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 60: Asia Pacific Prostate Health Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 61: Asia Pacific Prostate Health Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 62: Asia Pacific Prostate Health Market Value (US$ Mn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 63: Asia Pacific Prostate Health Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 64: Asia Pacific Prostate Health Market Value (US$ Mn) Share Analysis, by Treatment, 2023 and 2034
  • Figure 65: Asia Pacific Prostate Health Market Attractiveness Analysis, by Treatment, 2024-2034
  • Figure 66: Asia Pacific Prostate Health Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 67: Asia Pacific Prostate Health Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 68: Latin America Prostate Health Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 69: Latin America Prostate Health Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 70: Latin America Prostate Health Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 71: Latin America Prostate Health Market Value (US$ Mn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 72: Latin America Prostate Health Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 73: Latin America Prostate Health Market Value (US$ Mn) Share Analysis, by Treatment, 2023 and 2034
  • Figure 74: Latin America Prostate Health Market Attractiveness Analysis, by Treatment, 2024-2034
  • Figure 75: Latin America Prostate Health Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 76: Latin America Prostate Health Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 77: Middle East & Africa Prostate Health Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 78: Middle East & Africa Prostate Health Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 79: Middle East & Africa Prostate Health Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 80: Middle East & Africa Prostate Health Market Value (US$ Mn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 81: Middle East & Africa Prostate Health Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 82: Middle East & Africa Prostate Health Market Value (US$ Mn) Share Analysis, by Treatment, 2023 and 2034
  • Figure 83: Middle East & Africa Prostate Health Market Attractiveness Analysis, by Treatment, 2024-2034
  • Figure 84: Middle East & Africa Prostate Health Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 85: Middle East & Africa Prostate Health Market Attractiveness Analysis, by Distribution Channel, 2024-2034